Skip to content
Screener

Twist Bioscience Corporation TWST Other Income (Expense)

Other Income (Expense) at other companies

Danaher logo
DanaherDHR
-$3M+92.9%
Azenta logo
AzentaAZTA
$1.2M+246%
Agilent Technologies logo
Agilent TechnologiesA
$21M+184%
Illumina logo
IlluminaILMN
$15M-83.7%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$3.81M-71.2%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$910K-86.8%

Segments

By segment

See full
Reportable Segment$175K+144%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Total costs and expenses$156,578$134,353$293,176$257,711
Loss from operations$(45,863)$(41,560)$(78,763)$(76,205)
Interest income1,7102,8013,8856,041
Other income (expense), net[1]175(394)646(487)
Loss before income taxes$(43,978)$(39,153)$(74,232)$(70,651)
Income tax expense(43)(175)(296)(271)
Net loss$(44,021)$(39,328)$(74,528)$(70,922)
Other comprehensive loss:

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's other income (expense)?
Twist Bioscience Corporation (TWST) reported other income (expense) of $175K in Q1 2026.
How has Twist Bioscience Corporation's other income (expense) changed year-over-year?
Twist Bioscience Corporation's other income (expense) increased by 144.4% year-over-year, from -$394K to $175K.
What is the long-term trend for Twist Bioscience Corporation's other income (expense)?
Over 3 years (2021 to 2024), Twist Bioscience Corporation's other income (expense) has grown at a 25.1% compound annual growth rate (CAGR), from -$1.37M to -$2.68M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Twist Bioscience Corporation's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude